Patents by Inventor Kurt Ingmar Lovgren

Kurt Ingmar Lovgren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5817338
    Abstract: A new pharmaceutical multiple unit tableted dosage form containing omeprazole or one of its single enantiomers or an alkaline salt of omeprazole or one of its single enantiomers, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.
    Type: Grant
    Filed: June 20, 1995
    Date of Patent: October 6, 1998
    Assignee: Astra Aktiebolag
    Inventors: Pontus John Arvid Bergstrand, Kurt Ingmar Lovgren
  • Patent number: 5753265
    Abstract: A new pharmaceutical multiple unit tableted dosage form containing as active ingredient an acid labile H.sup.+ K.sup.+ -ATPase inhibitor or an alkaline salt thereof or one of its single enantiomers or an alkaline salt thereof, a method for the manufacture of such a formulation, and the method of treatment with such a formulation in medicine.
    Type: Grant
    Filed: June 22, 1995
    Date of Patent: May 19, 1998
    Assignee: Astra Aktiebolag
    Inventors: Pontus John Arvid Bergstrand, Kurt Ingmar Lovgren
  • Patent number: 5690960
    Abstract: A new oral pharmaceutical formulation containing a novel physical form of a magnesium salt of omeprazole, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.
    Type: Grant
    Filed: September 27, 1994
    Date of Patent: November 25, 1997
    Assignee: Astra Aktiebolag
    Inventors: Inga Siv Bengtsson, Kurt Ingmar Lovgren